Finerenone use in trial patients with HFpEF or HFmrEF increased hyperkalemia risk, especially in those with CKD. Finerenone use in patients with heart failure and preserved or mildly reduced ejection ...

Heart failure patients treated with finerenone (Kerendia; Bayer AG) are more likely to have an early decline in kidney function than those treated with placebo, but the decline should not be construed ...

Copyright: © 2024 The Author(s). Published by Elsevier Ltd.

Best whey-protein powders Best collagen-protein powder Best plant-based protein powders All the other protein powders I’ve tried Protein powders can be found in thousands of formulations on tens ...

Berlin: Bayer has announced the submission of marketing authorization applications to the U.S. Food and Drug Administration (US FDA) and to the Center of Drug Evaluation (CDE) of China’s National ...

Bayer's big investment in time and money on the development of finerenone for chronic kidney disease (CKD) in diabetics has paid off with an FDA approval, although it could face stiff competition ...

The FINEARTS-HF study highlights these principles in people with heart failure and mildly reduced or preserved ejection fraction, and illustrates both the metabolic and cardiovascular benefits of ...

Kerenida is currently approved to slow the progression of chronic kidney disease associated with type 2 diabetes. Bayer has submitted a supplemental new drug application (sNDA) for Kerendia ...

In the 1850s, steam-powered machines allowed for the mass production of cocoa powder. Today, over 4.5 million tons of cocoa are consumed around the world every year. Cocoa powder is made from ...